Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Avidity Biosciences (RNA) over the last 6 years, with Sep 2025 value amounting to -$587.9 million.

  • Avidity Biosciences' Cash from Investing Activities fell 21.87% to -$587.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$309.4 million, marking a year-over-year increase of 58.13%. This contributed to the annual value of -$854.2 million for FY2024, which is 556.72% down from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Cash from Investing Activities is -$587.9 million, which was down 416.97% from $185.5 million recorded in Q2 2025.
  • Over the past 5 years, Avidity Biosciences' Cash from Investing Activities peaked at $185.5 million during Q2 2025, and registered a low of -$587.9 million during Q3 2025.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$32.7 million (2024), whereas its average is -$111.8 million.
  • Within the past 5 years, the most significant YoY rise in Avidity Biosciences' Cash from Investing Activities was 1,466.50% (2022), while the steepest drop was 33,323.81% (2022).
  • Over the past 5 years, Avidity Biosciences' Cash from Investing Activities (Quarterly) stood at -$84.1 million in 2021, then spiked by 90.76% to -$7.8 million in 2022, then spiked by 757.05% to $51.0 million in 2023, then slumped by 225.73% to -$64.2 million in 2024, then dropped by 21.87% to -$587.9 million in 2025.
  • Its Cash from Investing Activities stands at -$587.9 million for Q3 2025, versus $185.5 million for Q2 2025 and $157.2 million for Q1 2025.